Aristo Bio-Tech and Lifescience Limited Sustainability Profile
Aristo Bio-Tech and Lifescience Limited, headquartered in India, is a prominent player in the biotechnology and life sciences sector. Founded in 2005, the company has established itself as a leader in the development and manufacturing of innovative biopharmaceuticals and healthcare solutions. With a strong operational presence across various regions in India, Aristo Bio-Tech focuses on delivering high-quality products that cater to the evolving needs of the healthcare industry. The company’s core offerings include a diverse range of biopharmaceuticals, including vaccines and therapeutic proteins, distinguished by their advanced formulation and efficacy. Aristo Bio-Tech's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. With a reputation for excellence and a dedication to improving patient outcomes, Aristo Bio-Tech continues to make strides in the life sciences landscape.
DitchCarbon Score
How does Aristo Bio-Tech and Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aristo Bio-Tech and Lifescience Limited's score of 9 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aristo Bio-Tech and Lifescience Limited's reported carbon emissions
Aristo Bio-Tech and Lifescience Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, the organisation's climate commitments and initiatives remain unclear. Without emissions data or reduction strategies, it is challenging to assess their environmental impact or commitment to sustainability. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change. However, Aristo Bio-Tech and Lifescience Limited has yet to establish a public framework or commitment in this regard.
How Carbon Intensive is Aristo Bio-Tech and Lifescience Limited's Industry?
How Carbon Intensive is Aristo Bio-Tech and Lifescience Limited's Location?
Aristo Bio-Tech and Lifescience Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aristo Bio-Tech and Lifescience Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
